Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Is The Sickle Cell Disease Treatment Market Expected To Grow In Terms Of Size?

The market size for the treatment of sickle cell disease has experienced considerable growth in the last few years. It is projected to increase from $2.95 billion in 2024 to $3.51 billion in 2025, with a compound annual growth rate (CAGR) of 18.7%. The significant growth observed in the historic period is due to better comprehension of the disease, blood transfusions, managing pain, and the utilization of hydroxyurea therapy.

In the coming years, the market size for sickle cell disease treatment is anticipated to witness an accelerated expansion. It’s predicted to reach $6.72 billion by 2029 with a compound annual growth rate (CAGR) of 17.7%. The increase in the projected period can be linked to factors such as gene editing and gene therapy, the development of new drugs, telemedicine and remote monitoring, as well as global health initiatives. Significant trends for the same period comprise curative therapies, alternative pain management methods, global partnerships, along with patient advocacy and engagement.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13048&type=smp

Which Key Factors Are Fueling Growth In The Sickle Cell Disease Treatment Market?

The surge in the need for blood transfusions is predicted to stimulate the expansion of the sickle cell disease treatment market in the future. A blood transfusion, a medical process where blood or blood components are transferred from a donor to a recipient, is essential for treating sickle cell disease (SCD) patients because it enhances the capacity of the blood to transport oxygen and reduces the problems linked to vaso-occlusion. For example, Mid-Atlantic Long-Term Care, a US-based organization offering specialised 24-hour on-call triage services, reported in January 2022 that around 29,000 units of red blood cells, 5,000 units of platelets and 6,500 units of plasma are required daily in the US. Hence, the escalating demand for blood transfusions is boosting the sickle cell disease treatment market’s progression.

How Is The Sickle Cell Disease Treatment Market Categorized Across Applications And Types?

The sickle cell disease treatmentmarket covered in this report is segmented –

1) By Treatment Modality: Blood Transfusion; Pharmacotherapy; Bone Marrow Transplant

2) By Disease Type: Sickle Cell Anemia; Hemoglobin Sickle C Disease (HbSC); Other Disease Types

3) By Route Of Administration: Oral; Parenteral

4) By End-User: Hospitals; Specialty Clinics; Other End-Users

Subsegments:

1) By Blood Transfusion: Regular Blood Transfusion; Exchange Transfusion

2) By Pharmacotherapy: Hydroxyurea; L-Glutamine; Voxelotor; Crizanlizumab

3) By Bone Marrow Transplant: Allogeneic Transplant; Autologous Transplant

How Are Industry Trends Steering The Expansion Of The Sickle Cell Disease Treatment Market?

Leading firms in the market for sickle cell disease treatment are directing their focus towards the creation of new oral suspension drugs. The aim is to enhance patient adherence, boost the effectiveness of the drug, and offer easier treatment methods, particularly for pediatric and older patients. Oral suspension medications, which are liquid medicines containing solid particles mixed within a liquid, are designed to simplify the process of swallowing for patients, especially children and those who find difficulty in swallowing pills. For example, Akums Drugs and Pharmaceuticals Ltd., an Indian pharmaceutical preparation manufacturing company, introduced a Hydroxyurea oral suspension that can be stored at room temperature in March 2024. This SCD medication is not only affordable but is also stable at room temperature, thereby enhancing its reach in India. With a price tag that is less than 1% of the imported alternatives, it facilitates accurate dosing via oral syringes which benefits patients across all age groups without necessitating the requirement for cold storage.

Which Firms Are Making The Biggest Impact In The Sickle Cell Disease Treatment Market?

Major companies operating in the sickle cell disease treatment market are Sun Pharmaceutical Industries Ltd., Pfizer Inc., Johnson & Johnson Private Limited, Merck & Co Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Incorporated, Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Silver Lake Research Corporation0.45, Global Blood Therapeutics Inc., Acceleron Pharma Inc., Sangamo Therapeutics Inc., Medunik USA Inc., Zydus Cadila Healthcare Ltd., Graphite Bio Inc., Addmedica, Emmaus Medical Inc., Bluebird bio Inc., CRISPR Therapeutics AG, GlycoMimetics Inc., Arena Pharmaceuticals Inc., Mast Therapeutics Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/sickle-cell-disease-treatment-global-market-report

Which Region Holds The Greatest Opportunity For Sickle Cell Disease Treatment Market Expansion?

North America was the largest region in the sickle cell disease treatment market in 2024. The regions covered in sickle cell disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=13048&type=smp

Browse Through More Reports Similar to the Global Sickle Cell Disease Treatment Market 2025, By The Business Research Company

Blood Transfusion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Patient Blood Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report

Anemia And Other Blood Disorder Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model